From quinine to synthetic antimalarials: knowledge of medicinal plants as a potential strategy in CoVID-19 therapy

Detalhes bibliográficos
Autor(a) principal: Bizarri, Carlos Henrique Brasil
Data de Publicação: 2021
Outros Autores: Rezende, Mayara de Azeredo, Mattos, Aline Estácio Ribeiro de, Nóbrega, Andrea Bezerra da, Villas Bôas, Glauco de Kruse
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Fitos
Texto Completo: https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1086
Resumo: CoVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which has complex symptoms, affecting various human organs. Antimalarial plants can also have important pharmacological activities in the treatment of other diseases. Thus, plants with antimalarial activity have been the target of studies for the treatment of CoVID-19. The aim of this study was to verify in the scientific literature the use of medicinal plants with antimalarial activity as a potential strategy therapy in CoVID-19. Therefore, research, systematization of articles and literature reviews of plants with antimalarial, antiviral, anti-inflammatory, and immunomodulatory activity published in the last 20 years were carried out. The 27 important plant species with antimalarial activity were listed. Among these, plants of the genera Cinchona and Artemisia stood out for presenting antimalarial and antiviral activities, with the main major constituents responsible for these activities, quinine and artemisinin, respectively. Based on the findings of this study, it is possible to highlight the importance and urgency of research and development of medicines derived from plant diversity, considering the multiplicity of pharmacological actions that the selected plants present, which could potentially be applicable in therapy against CoVID-19.
id FIOCRUZ-1_ed3aadc304ad36dcc24c8f64180d9521
oai_identifier_str oai:ojs.revistafitos.far.fiocruz.br:article/1086
network_acronym_str FIOCRUZ-1
network_name_str Revista Fitos
repository_id_str
spelling From quinine to synthetic antimalarials: knowledge of medicinal plants as a potential strategy in CoVID-19 therapyDo quinino aos antimaláricos sintéticos: o conhecimento das plantas medicinais como estratégia potencial na terapia da CoVID-19Medicinal plantsSARS-CoV-2CoVID-19AntiviralAnti-inflammatoryImmunomodulatoryPlantas medicinaisSARS-CoV-2COVID-19Antiviralação anti-inflamatóriaImunomoduladoraCoVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which has complex symptoms, affecting various human organs. Antimalarial plants can also have important pharmacological activities in the treatment of other diseases. Thus, plants with antimalarial activity have been the target of studies for the treatment of CoVID-19. The aim of this study was to verify in the scientific literature the use of medicinal plants with antimalarial activity as a potential strategy therapy in CoVID-19. Therefore, research, systematization of articles and literature reviews of plants with antimalarial, antiviral, anti-inflammatory, and immunomodulatory activity published in the last 20 years were carried out. The 27 important plant species with antimalarial activity were listed. Among these, plants of the genera Cinchona and Artemisia stood out for presenting antimalarial and antiviral activities, with the main major constituents responsible for these activities, quinine and artemisinin, respectively. Based on the findings of this study, it is possible to highlight the importance and urgency of research and development of medicines derived from plant diversity, considering the multiplicity of pharmacological actions that the selected plants present, which could potentially be applicable in therapy against CoVID-19.CoVID-19 é uma doença infecciosa causada pelo vírus SARS-CoV-2, que apresenta uma sintomatologia complexa, atingindo vários órgãos e sistemas do organismo humano. Estudos com plantas medicinais indicam as diversas atividades farmacológicas que uma mesma espécie vegetal pode apresentar. Plantas com atividade antimalárica têm sido alvo de estudos para o tratamento da CoVID-19, através de suas ações combatendo diretamente o vírus, como na redução ou eliminação dos sintomas. O objetivo deste estudo foi verificar, na literatura científica, o uso das plantas medicinais com atividade antimalárica como potencial estratégia na terapia da CoVID-19. Foram realizadas pesquisa, sistematização de artigos e revisões da literatura de plantas com atividade antimalárica, antiviral, anti-inflamatória e imunomoduladora publicados nos últimos 20 anos. Listou-se 27 espécies de plantas importantes com atividade antimalárica. Dentre essas, plantas dos gêneros Cinchona e Artemisia destacaram-se por apresentarem atividades antimalárica e antiviral, tendo como principais constituintes majoritários, responsáveis por estas atividades, a quinina e a artemisinina, respectivamente. Foi possível destacar a importância e urgência da pesquisa e do desenvolvimento de medicamentos provenientes da diversidade vegetal, considerando a multiplicidade de ações farmacológicas que as plantas selecionadas apresentam, podendo ser potencialmente aplicáveis ​​na terapia contra a CoVID-19.Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz2021-09-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmltext/xmltext/htmlhttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/108610.32712/2446-4775.2021.1086Revista Fitos; Vol. 15 No. 3 (2021); 366-384Revista Fitos; Vol. 15 Núm. 3 (2021); 366-384Revista Fitos; v. 15 n. 3 (2021); 366-3842446-47751808-9569reponame:Revista Fitosinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1086/785https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1086/786https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1086/973https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1086/903Copyright (c) 2021 Revista Fitoshttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccess Bizarri, Carlos Henrique BrasilRezende, Mayara de AzeredoMattos, Aline Estácio Ribeiro deNóbrega, Andrea Bezerra daVillas Bôas, Glauco de Kruse2022-05-02T19:41:05Zoai:ojs.revistafitos.far.fiocruz.br:article/1086Revistahttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/PUBhttp://revistafitos.far.fiocruz.br/index.php/revista-fitos/oairevistafitos@far.fiocruz.br || eugenio.telles@far.fiocruz.br2446-47752446-4775opendoar:2022-05-02T19:41:05Revista Fitos - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv From quinine to synthetic antimalarials: knowledge of medicinal plants as a potential strategy in CoVID-19 therapy
Do quinino aos antimaláricos sintéticos: o conhecimento das plantas medicinais como estratégia potencial na terapia da CoVID-19
title From quinine to synthetic antimalarials: knowledge of medicinal plants as a potential strategy in CoVID-19 therapy
spellingShingle From quinine to synthetic antimalarials: knowledge of medicinal plants as a potential strategy in CoVID-19 therapy
Bizarri, Carlos Henrique Brasil
Medicinal plants
SARS-CoV-2
CoVID-19
Antiviral
Anti-inflammatory
Immunomodulatory
Plantas medicinais
SARS-CoV-2
COVID-19
Antiviral
ação anti-inflamatória
Imunomoduladora
title_short From quinine to synthetic antimalarials: knowledge of medicinal plants as a potential strategy in CoVID-19 therapy
title_full From quinine to synthetic antimalarials: knowledge of medicinal plants as a potential strategy in CoVID-19 therapy
title_fullStr From quinine to synthetic antimalarials: knowledge of medicinal plants as a potential strategy in CoVID-19 therapy
title_full_unstemmed From quinine to synthetic antimalarials: knowledge of medicinal plants as a potential strategy in CoVID-19 therapy
title_sort From quinine to synthetic antimalarials: knowledge of medicinal plants as a potential strategy in CoVID-19 therapy
author Bizarri, Carlos Henrique Brasil
author_facet Bizarri, Carlos Henrique Brasil
Rezende, Mayara de Azeredo
Mattos, Aline Estácio Ribeiro de
Nóbrega, Andrea Bezerra da
Villas Bôas, Glauco de Kruse
author_role author
author2 Rezende, Mayara de Azeredo
Mattos, Aline Estácio Ribeiro de
Nóbrega, Andrea Bezerra da
Villas Bôas, Glauco de Kruse
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Bizarri, Carlos Henrique Brasil
Rezende, Mayara de Azeredo
Mattos, Aline Estácio Ribeiro de
Nóbrega, Andrea Bezerra da
Villas Bôas, Glauco de Kruse
dc.subject.por.fl_str_mv Medicinal plants
SARS-CoV-2
CoVID-19
Antiviral
Anti-inflammatory
Immunomodulatory
Plantas medicinais
SARS-CoV-2
COVID-19
Antiviral
ação anti-inflamatória
Imunomoduladora
topic Medicinal plants
SARS-CoV-2
CoVID-19
Antiviral
Anti-inflammatory
Immunomodulatory
Plantas medicinais
SARS-CoV-2
COVID-19
Antiviral
ação anti-inflamatória
Imunomoduladora
description CoVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which has complex symptoms, affecting various human organs. Antimalarial plants can also have important pharmacological activities in the treatment of other diseases. Thus, plants with antimalarial activity have been the target of studies for the treatment of CoVID-19. The aim of this study was to verify in the scientific literature the use of medicinal plants with antimalarial activity as a potential strategy therapy in CoVID-19. Therefore, research, systematization of articles and literature reviews of plants with antimalarial, antiviral, anti-inflammatory, and immunomodulatory activity published in the last 20 years were carried out. The 27 important plant species with antimalarial activity were listed. Among these, plants of the genera Cinchona and Artemisia stood out for presenting antimalarial and antiviral activities, with the main major constituents responsible for these activities, quinine and artemisinin, respectively. Based on the findings of this study, it is possible to highlight the importance and urgency of research and development of medicines derived from plant diversity, considering the multiplicity of pharmacological actions that the selected plants present, which could potentially be applicable in therapy against CoVID-19.
publishDate 2021
dc.date.none.fl_str_mv 2021-09-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1086
10.32712/2446-4775.2021.1086
url https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1086
identifier_str_mv 10.32712/2446-4775.2021.1086
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1086/785
https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1086/786
https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1086/973
https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1086/903
dc.rights.driver.fl_str_mv Copyright (c) 2021 Revista Fitos
https://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Revista Fitos
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
text/xml
text/html
dc.publisher.none.fl_str_mv Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz
publisher.none.fl_str_mv Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz
dc.source.none.fl_str_mv Revista Fitos; Vol. 15 No. 3 (2021); 366-384
Revista Fitos; Vol. 15 Núm. 3 (2021); 366-384
Revista Fitos; v. 15 n. 3 (2021); 366-384
2446-4775
1808-9569
reponame:Revista Fitos
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Revista Fitos
collection Revista Fitos
repository.name.fl_str_mv Revista Fitos - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv revistafitos@far.fiocruz.br || eugenio.telles@far.fiocruz.br
_version_ 1798313475524526080